Develops drugs for neurological disorders, including epilepsy and movement disorders.
Dec 2025Revenue $0.00/yrExpenses $326M/yr
No trendCash runway ≈ 2.5 years from Jun 2026
Figures by year
When will Praxis Precision Medicines be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $0.00 and expenses $326M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $0.00 | $326M | −$326M |
| Dec 2024 | $8.55M | $209M | −$200M |
| Dec 2023 | $2.45M | $129M | −$126M |
| Dec 2022 | $0.00 | $215M | −$215M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.